Alison Mercier Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 901 Lakeshore Dr, Ishpeming, MI 49849 Phone: 906-485-2261 |
Mr. Andrew James Kangas, MOT, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 435 Stoneville Rd, Ishpeming, MI 49849 Phone: 906-485-1073 |
Natalie R Hutter Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 901 Lakeshore Dr, Ishpeming, MI 49849 Phone: 906-485-4431 |
Jesse O'kelly Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Saginaw St, Ishpeming, MI 49849 Phone: 906-204-1109 |
Diana Reams, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 435 Stoneville Rd, Ishpeming, MI 49849 Phone: 906-485-1073 |
Audrey Geneane Siders, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 818 N Pine St, Ishpeming, MI 49849 Phone: 810-280-6367 |
Brooke Ann Montgomery, MS, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 901 Lakeshore Dr, Ishpeming, MI 49849 Phone: 906-486-4431 |
Mr. John Gray Graham, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 97 S 4th St, Ishpeming, MI 49849 Phone: 906-485-2775 Fax: 906-486-1136 |
Richard Keith Matthews, OTRL, CHT Occupational Therapist - Hand Medicare: Not Enrolled in Medicare Practice Location: 901 Lakeshore Dr, Ishpeming, MI 49849 Phone: 906-485-2261 Fax: 906-485-2506 |
Mrs. Kirsten R Matthews, MA, OTRL, CLT Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 97 S 4th St, Suite B, Ishpeming, MI 49849 Phone: 906-485-2775 Fax: 906-486-1136 |
News Archive
A five per cent difference in favor of the 48 hours. This is the result of a study from Aarhus University that has spent several years examining the possible benefits of cooling down patients suffering cardiac arrest to 33°C for 48 hours, instead of the 24-hours that is standard practice in most places.
IQ Therapeutics B.V., Groningen, the Netherlands, announced this week that in collaboration with the University of Texas Medical Branch it has obtained outstanding results for the treatment of inhalation anthrax. In a rabbit model up to 100% survival could be achieved with extended time to treatment (48h post infection) with a combination of two specific monoclonal antibodies developed by IQ Therapeutics. This has significant potential for saving lives of infected people who have no immediate access to treatment.
Patients treated by older hospital-based internists known as hospitalists are somewhat more likely to die within a month of admission than those treated by younger physicians, according to the results of a study led by researchers at Harvard Medical School and Harvard T.H. Chan School of Public Health.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that consolidation treatment with fractionated yttrium-90 (Y-90) labeled epratuzumab, after induction therapy with rituximab and CHOP (R-CHOP) chemotherapy, improved remission status of adult patients with diffuse large B-cell lymphoma (DLBCL), a form of aggressive lymphoma.
› Verified 5 days ago